Search the hub
Showing results for tags 'China'.
Found 5 results
-
News Article
UK Biobank health data listed for sale in China, government confirms
Patient Safety Learning posted a news article in News
Medical information of 500,000 participants of one of the UK's landmark scientific programmes, UK Biobank, were offered for sale online in China, the government has confirmed. Technology minister Ian Murray said information of all members of the database was found listed for sale on the website Alibaba. Murray told MPs the charity which runs UK Biobank had told the government about the breach on Monday. He said the information did not include names, addresses, contact details or telephone numbers. However he said it could include gender, age, month and year of birth, socioeconomic status, lifestyle habits, and measures from biological samples. The Biobank is a collection of health data offered by volunteers which has been used to help improvements in detection and treatment of dementia, some cancers and Parkinson's. It has collected intimate details - including whole body scans, DNA sequences and their medical records - from hundreds of thousands of volunteers for over two decades. The project has led to more than 18,000 scientific publications. Participants were aged from 40 to 69 when they were recruited between 2006 and 2010. "We understand that the existence of these listings, even temporarily, will be concerning to you," Chief Executive Professor Sir Rory Collins said in a message to participants, external. "We want to reassure you that all the data are de-identified; they do not contain any personally identifying information (such as names, addresses, dates of birth, and NHS numbers)." Read full story Source: BBC News, 23 April 2026 -
Content ArticleThis study in Jama Network Open examines the health outcomes of patients who were hospitalised with COVID-19 in two Wuhan hospitals between February and April 2020. The authors found that: 45 percent of patients reported at least one symptom one year after hospitalisation the most common symptoms that patients reported were fatigue, sweating, chest tightness, anxiety and muscle pain patients who experienced severe disease during hospitalisation were more likely to experience more symptoms of long-COVID one year on patients who experienced severe disease were likely to have higher chronic obstructive pulmonary disease (COPD) assessment test scores that patients with less severe disease.
-
Content ArticleSecond victims, defined as healthcare providers enduring emotional and psychological distress after patient safety incidents (PSIs). The potential for positive transformation through these experiences is underexplored but is essential for fostering a culture of error learning and enhancing patient care. This study explored the level and determinants of post-traumatic growth (PTG), applying the stress process model. It provides novel insights into the complex interplay between perceived threats, coping styles, and social support in facilitating PTG among second victims. By bolstering social support and promoting adaptive coping strategies, the adverse effects of PSIs can be mitigated, transforming them into opportunities for resilience and growth, and offering a fresh perspective on managing PSIs in healthcare settings.
-
Content ArticlePatient safety culture (PSC) is crucial for reducing medical errors and improving patient outcomes globally. This study aims to identify key improvement targets in China’s PSC to promote a safer healthcare environment. It found that while teamwork is a notable strength, there is room to enhance the nonpunitive response to errors. Improving feedback and communication practices can further bolster openness and collaboration within teams, leading to an overall healthier work environment.
-
Content ArticleMedication safety is a significant concern around the world. Patient participation in the medication process is effective in reducing the incidence of medication errors and improving medication safety. However, the role of outpatients with chronic conditions in ensuring medication safety is often neglected. This study aims to explore the perspectives and experiences of GPs, pharmacists, and outpatients by qualitative interviews in Beijing, China. The study involved a series of interviews with eight GPs, seven pharmacists, and 18 outpatients living with noncommunicable diseases. The interview revealed five themes: (1) mutual trust between patient and GP, (2) communication with healthcare professionals, (3) acquisition of knowledge about medication safety, (4) implementation of medication self-management at home, and (5) different attitudes toward participation in medication decisions. The findings might help propose suggestions for patient participation in medication safety. Integrating these findings into future studies can help healthcare professionals formulate interventions and better support patients in participating in the medication process.
